Herpes Cure Advocacy is excited to announce we are pursuing filing as a non-profit organization with 501c3 status. Herpes Cure Advocacy is launching a small capital campaign to raise $25,000 – these funds will allow us to further our work to advance the treatment and prevention of Herpes Simplex Virus types 1 and 2 inContinue reading “Fundraising begins for a Herpes Cure”
Category Archives: Uncategorized
Testing and Diagnosis for Herpes: A Dialogue
Herpes Cure Advocacy is proud to offer a 2-part webinar series in partnership with NCSD. STI Testing and Diagnosis for Herpes is Challenging Testing for HSV, especially of asymptomatic infection, is complex and can be challenging for both patient and clinician alike. Join our two-part workshop for an open and safe dialogue to learn, askContinue reading “Testing and Diagnosis for Herpes: A Dialogue”
Monoclonal Antibodies: What’s in the pipeline for Herpes treatments?
What new treatments are coming for Herpes? In the Herpes Cure Pipeline, there are several monoclonal antibody treatments. What kind of advantages do monoclonal antibody (MAB) treatments have over anti-virals or therapeutic vaccines? What makes monoclonals work? In simple terms, monoclonal antibodies are lab developed antibodies that are directly injected into the body. The antibodiesContinue reading “Monoclonal Antibodies: What’s in the pipeline for Herpes treatments?”
Herpes Advocates: Nicole’s Story
Hi, my name is Nicole and I have always thought of myself as a good person. However, sometimes, life can throw you into a dark corner that you never even dreamed imaginable. My experience with HSV2 has been devastating. I am ashamed that I allowed this to happen to me and I turned around and infectedContinue reading “Herpes Advocates: Nicole’s Story”
Request a Patient Listening Session at the FDA
Hi there Herpes Advocates, we’re happy you’re here. Advocacy Alert: Request a Patient Listening Session at the FDA The landscape for prevention of HSV in America is inadequate. There is a critical loophole without an accurate test to diagnose asymptomatic infection. Currently available FDA-approved tests for HSV are inaccurate 50% of the time with confirmatoryContinue reading “Request a Patient Listening Session at the FDA”
Koda’s Patient Story
My diagnosis with HSV-1 was traumatic. It was a result of a date where the other party did not disclose their positive status. They had the virus for 10+ years and knew about it, yet did not tell me. When she revealed this to me, after I had already been exposed several times, it was tooContinue reading “Koda’s Patient Story”
After Covid-19 success, patients with the world’s ‘most stigmatized’ infection push for their own Operation Warp Speed
“There has not been any kind of herpes advocacy in the 30 years that I’ve been involved in STI prevention and research. It was something that was just never addressed,” said Jeff Klausner, an infectious disease physician at UCLA and the former director of STD prevention and control at San Francisco’s public health department. “There’sContinue reading “After Covid-19 success, patients with the world’s ‘most stigmatized’ infection push for their own Operation Warp Speed”
FY 2022 Budget Includes National Strategy and Strategic Plan for HSV
Herpes Cure Advocacy is pleased to report that with the passing of FY 2022 budget that the Dept. of Health and Human Services National Strategy and Strategic Plan for the treatment and prevention of Herpes Simplex Virus has a budget of $250,000. This small investment in strategic planning is an important step forward in theContinue reading “FY 2022 Budget Includes National Strategy and Strategic Plan for HSV”
Herpes Scientists Give Impacted Communities a Voice
The University of Washington Virology Division and the Vaccine and Infectious Disease Division at Fred Hutch Cancer Center have announced a new initiative for members of the communities affected by herpes simplex virus infection to join a new Community Advisory Board that will potentially inform future scientific research and/or clinical trials. Led by renowned herpesContinue reading “Herpes Scientists Give Impacted Communities a Voice”
IgM test removal at QUEST Diagnostics is a win for Herpes clinical care
Herpes Cure Advocacy celebrates and thanks Quest Diagnostics for removing the HSV 1/2 IgM test from their product offerings. Quest Diagnostic joins Mayo Clinic in the removal of this test from their product offerings. This is a win for herpes advocacy and a small step forward to better clinical care for Herpes Simplex Virus inContinue reading “IgM test removal at QUEST Diagnostics is a win for Herpes clinical care”